<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28218" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Radiopharmaceuticals</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Munjal</surname>
            <given-names>Akul</given-names>
          </name>
          <aff>Medical College of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Nishant</given-names>
          </name>
          <aff>Columbia University at Bassett Medical Center, NY, USA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Akul Munjal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishant Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28218.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Radiopharmaceuticals include a group of radioactive agents used for either diagnostic or therapeutic interventions.&#x000a0;Although the administration of radiopharmaceuticals is often systemic, they are likely to localize to specific tissues because of their biomolecular properties, i.e., the areas of hyperintensity observed on positron emission tomography (PET) scans that indicate a high tissue metabolic demand.&#x000a0;Radiopharmaceuticals actively emit radiation, which makes their storage more difficult than non-radioactive pharmaceuticals. Compounds used for diagnostic interventions&#x000a0;usually either emit beta particles (positrons or electrons) or gamma rays, while compounds that emit Auger electrons or alpha particles (helium nuclei) are generally for therapeutic interventions.&#x000a0;</p>
        <p>Radio-imaging involves the use of incredibly low concentrations of radiotracers (sub-micro quantities). Radio-imaging is currently used to analyze tissue physiology, detect disease, and monitor treatments; however, new uses are being discovered with the advent of personalized medicine.&#x000a0;&#x000a0;</p>
        <p>Radiotherapeutic agents use the radiation emitted from the nuclide to kill the target cells or serve palliative purposes. Radiation is toxic to tissues in the body: the brain, spinal cord, kidneys, and bone marrow are especially susceptible. Many radiopharmaceuticals are delivered systemically, and this means that&#x000a0;ideally, the pharmaceuticals should selectively prefer the tumor tissue relative to normal healthy tissue.&#x000a0;Many various specific radionuclides are in common use.<xref ref-type="bibr" rid="article-28218.r1">[1]</xref><xref ref-type="bibr" rid="article-28218.r2">[2]</xref></p>
      </sec>
      <sec id="article-28218.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Technetium-99m is one of the most common radionuclides used. It is a gamma emitter that is primarily used in diagnostic imaging and has limited therapeutic utility. Its use is in imaging: the thyroid, lacrimal glands, vascular perfusion, pulmonary perfusion, bones, myocardial, etc. It is the most common radionuclide used in diagnostic investigations. Many other radionuclides are also used, including but not limited to iodine-123, iodine-131, iron-55, selenium-75, sodium-22, strontium-89, thallium-201, xenon-133, etc.<xref ref-type="bibr" rid="article-28218.r3">[3]</xref><xref ref-type="bibr" rid="article-28218.r4">[4]</xref></p>
        <p>Iodine-131 is a radioisotope that has a broad array of applications. It undergoes beta decay, and it results in mutations in the cells that it penetrates. This characteristic gives it utility in thyroid ablations (the thyroid is the only organ in the body that&#x000a0;uses iodine), which is useful in treating various thyroid malignancies and can be used to treat refractory Graves disease. Iodine-131 results in mutations in the cells that uptake it; it is often used in large doses, as low doses can result in an increased risk of subsequent malignancies (incomplete tissue ablation). Iodine-131 is also a gamma emitter; however, due to malignancy risk, iodine-123 (a more pure gamma emitter) is used in nuclear medicine scans of the thyroid.<xref ref-type="bibr" rid="article-28218.r5">[5]</xref><xref ref-type="bibr" rid="article-28218.r6">[6]</xref></p>
        <p>Cesium-137 is a radioactive isotope of cesium that undergoes beta decay and gamma emission. The isotope is chemically unstable and quite reactive; thus, it is not routinely used in diagnostic modalities. It is primarily medically used for low-dose temporary intracavity brachytherapy.<xref ref-type="bibr" rid="article-28218.r7">[7]</xref></p>
        <p>Fluorine-18 is a radioisotope of fluorine that primarily undergoes positron emission; however, it also undergoes electron capture. Fluorine-18's primary use is as a radiotracer for PET scans. Thallium has many isotopes; however, the most medically useful is thallium-201. Thallium-201 undergoes electron capture to emit X-rays and photons. This feature makes it useful in imaging studies, and it is often used in cardiac stress tests (a test used to assess myocardial perfusion). Xenon-133 is a radioisotope of xenon that undergoes Beta decay. It is an inhaled radionuclide that is used to assess pulmonary function and cerebral blood flow. Rubidium-82 is a radioisotope of rubidium that undergoes both positron and gamma emission. It is primarily administered IV to assess myocardial imaging.<xref ref-type="bibr" rid="article-28218.r8">[8]</xref><xref ref-type="bibr" rid="article-28218.r9">[9]</xref></p>
      </sec>
      <sec id="article-28218.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Radiopharmaceuticals are vital to healthcare. They are instrumental in imaging, and in the United States alone, millions of nuclear medicine procedures are performed annually. They are instrumental in the treatment of many malignancies and even many benign tumors.<xref ref-type="bibr" rid="article-28218.r10">[10]</xref><xref ref-type="bibr" rid="article-28218.r11">[11]</xref></p>
        <p>Designing radiopharmaceuticals is a rigorous and complicated process that relies on many different factors. Selecting the appropriate nuclide is critical, as the specific nuclide has a specific half-life and decay mode. These both impact the localization and utility of the radiopharmaceutical. Other factors, such as molecular stability, ease, and production cost, are also important factors.<xref ref-type="bibr" rid="article-28218.r12">[12]</xref><xref ref-type="bibr" rid="article-28218.r13">[13]</xref>&#x000a0;</p>
        <p>Specific radiopharmaceuticals like radium-223 are useful for treating painful bone metastases in prostate cancer patients with castration-resistant bone metastases and have been approved by the FDA for this use.<xref ref-type="bibr" rid="article-28218.r14">[14]</xref></p>
      </sec>
      <sec id="article-28218.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The use of radionuclides involves an interprofessional approach, and many different disciplines must work in tandem to deliver these toxic agents. Each healthcare team member must understand the critical nature of their role and what exactly it entails and provide input to ensure proper diagnostic results with no unnecessary risks to the patient.&#x000a0;Risks include extravasation, where radiopharmaceuticals are accidentally injected into the soft tissue surrounding the vein, which can cause harm to the patient and result in inaccurate readings for treatment. These should be recorded, reported and the patient informed.</p>
      </sec>
      <sec id="article-28218.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28218&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28218">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28218/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28218">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28218.s6">
        <title>References</title>
        <ref id="article-28218.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartholom&#x000e4;</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application.</article-title>
            <source>J Labelled Comp Radiopharm</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>9</issue>
            <fpage>715</fpage>
            <page-range>715-726</page-range>
            <pub-id pub-id-type="pmid">29524233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blower</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Zweit</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Copper radionuclides and radiopharmaceuticals in nuclear medicine.</article-title>
            <source>Nucl Med Biol</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>8</issue>
            <fpage>957</fpage>
            <page-range>957-80</page-range>
            <pub-id pub-id-type="pmid">9004284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelidis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giamouzis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karagiannis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tsougos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Valotassiou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Giannakoulas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dimakopoulos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Xanthopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skoularigis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Triposkiadis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Georgoulias</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>SPECT and PET in ischemic heart failure.</article-title>
            <source>Heart Fail Rev</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-261</page-range>
            <pub-id pub-id-type="pmid">28150111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mizunobu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sasao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Murai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Assessment of left ventricular systolic and diastolic function using ECG-gated technetium-99m tetrofosmin myocardial perfusion SPECT.</article-title>
            <source>Int Heart J</source>
            <year>2013</year>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>212</fpage>
            <page-range>212-5</page-range>
            <pub-id pub-id-type="pmid">23924933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thamcharoenvipas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tepmongkol</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Finding the best effective way of treatment for rapid I-131 turnover Graves' disease patients: A randomized clinical trial.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>May</month>
            <volume>98</volume>
            <issue>19</issue>
            <fpage>e15573</fpage>
            <pub-id pub-id-type="pmid">31083231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiani Nasab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rafat Motavalli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miri Hakimabad</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Internal dosimetry of inhaled iodine-131.</article-title>
            <source>J Environ Radioact</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>181</volume>
            <fpage>62</fpage>
            <page-range>62-69</page-range>
            <pub-id pub-id-type="pmid">29101822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viswanathan</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Ibbott</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Eifel</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.</article-title>
            <source>Brachytherapy</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-74</page-range>
            <pub-id pub-id-type="pmid">28109633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>French</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Brody</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von Stade</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Flourine-18 fluorodeoxyglucose positron emission tomography imaging exhibits increased SUVmax at the level of the spinal intumescence in normal dogs.</article-title>
            <source>Vet Radiol Ultrasound</source>
            <year>2020</year>
            <month>May</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>364</fpage>
            <page-range>364-369</page-range>
            <pub-id pub-id-type="pmid">31916651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reves</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Toward Understanding Cerebral Blood Flow during Cardiopulmonary Bypass: Implications for the Central Nervous System.</article-title>
            <source>Anesthesiology</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-613</page-range>
            <pub-id pub-id-type="pmid">30875356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Ross-Degnan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wharam</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Trends in Diagnostic Imaging Utilization among Medicare and Commercially Insured Adults from 2003 through 2016.</article-title>
            <source>Radiology</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>294</volume>
            <issue>2</issue>
            <fpage>342</fpage>
            <page-range>342-350</page-range>
            <pub-id pub-id-type="pmid">31891320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Duszak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Rosenkrantz</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Changing Utilization of Noninvasive Diagnostic Imaging Over 2 Decades: An Examination Family-Focused Analysis of Medicare Claims Using the Neiman Imaging Types of Service Categorization System.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>210</volume>
            <issue>2</issue>
            <fpage>364</fpage>
            <page-range>364-368</page-range>
            <pub-id pub-id-type="pmid">29220208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>WZ</given-names>
              </name>
            </person-group>
            <article-title>Drug Design and Discovery: Principles and Applications.</article-title>
            <source>Molecules</source>
            <year>2017</year>
            <month>Feb</month>
            <day>13</day>
            <volume>22</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28208821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baig</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Adil</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kamal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Provazn&#x000ed;k</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Computer Aided Drug Design: Success and Limitations.</article-title>
            <source>Curr Pharm Des</source>
            <year>2016</year>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>572</fpage>
            <page-range>572-81</page-range>
            <pub-id pub-id-type="pmid">26601966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28218.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Devgan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Olsavsky</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abdelbaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of radium-223 in patients with bone metastases.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-426</page-range>
            <pub-id pub-id-type="pmid">28966451</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
